Cited by 942Cytokine Signaling Pathways and InteractionsImmunodeficiency and Autoimmune DisordersNF-κB Signaling Pathways

The DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.

JAKs and STATs in Immunity, Immunodeficiency, and Cancer

Open access

O'Shea, John J., Holland, Steven M., Staudt, Louis M.·2013·New England Journal of Medicine

DOI 10.1056/nejmra1202117PMC PMC7604876

Open this paper in CoChat — free account

Abstract

A large number of cytokines signal through the JAK–STAT pathway. Abnormal function of this pathway may lead to a variety of diseases. Targeting the defects in this signaling pathway has already led to treatment advances, and further advances are likely.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmra1202117

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Couedic, J. P. L., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslová, H., Berger, R., Griscelli, A. B., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,542
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis
Verstovsek, S., Mesa, R. A., Gotlib, J., Levy, R. S., Gupta, V., DiPersio, J. F., Catalano, J. V., Deininger, M., Miller, C., Silver, R. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110557 · Cited by 2,103
JAKS AND STATS: Biological Implications
Leonard, W. J., & O’Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,826
Self-citation
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis
Harrison, C., Kiladjian, J.-J., Al-Ali, H. K., Gisslinger, H., Waltzman, R., Stalbovskaya, V., McQuitty, M., Hunter, D. S., Levy, R., Knoops, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110556 · Cited by 1,825
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596

Show all 101 references

Research works printed but not linked: 1

10.1172/JCI0215617 · DOI

Sorted by citations

Items 601–700 of 942

Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE)
Tran, A. P., Tassone, D., Nossent, J. C., & Ding, N. S. (2022) · RMD Open · doi:10.1136/rmdopen-2022-002301 · Cited by 7
Short Peptide Type I Interferon Mimetics: Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections
Ahmed, C. M. I., & Johnson, H. M. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0041 · Cited by 7
Jak-STAT Signaling Pathways
Zhang, H., Li, H. S., & Watowich, S. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.11015-x · Cited by 7
A review of Janus kinase/signal transducer and activator of transcription signaling and cytokines in the pain mechanism of rheumatoid arthritis
Xiong, Y., Song, X., Sheng, X., Wu, J. H., Chang, X., Ren, T., Cao, J., Cheng, T., & Wang, M. (2023) · European Journal of Inflammation · doi:10.1177/1721727x231197498 · Cited by 6
JSI-124 Induces Cell Cycle Arrest and Regulates the Apoptosis in Glioblastoma Cells
Tsai, T., Lee, K.-T., & Hsu, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11112999 · Cited by 6
Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID
Liu, A., Liu, Q., Leng, S., Zhang, X., Qi, F., Peng, J., & Feng, G. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac121 · Cited by 6
ITGAM-macrophage modulation as a potential strategy for treating neutrophilic Asthma: insights from bioinformatics analysis and in vivo experiments
Yan, Q., Liu, Z., Chen, Y., Zhang, X., Zheng, W., Liu, X., Huang, H.-T., Liu, Q., Jiang, Y. Q., Zhan, S., et al. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01914-5 · Cited by 6
Chrysin alleviates DNA damage to improve disturbed immune homeostasis and pro-angiogenic environment in laser-induced choroidal neovascularization
Wang, J., Wang, Z., Liu, J., Zhou, M., Wang, H., Zhu, H., Jiang, M., Bo, Q., & Sun, X. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119657 · Cited by 7
Elevated Immunoglobulin E Serum Levels: Possible Underlying Factors That Can Cause an Inborn Error of Immunity in the Pediatric Population with Recurrent Infections
Oprițescu, S., Nițescu, G. V., Cîrnaţu, D., Trifunschi, S., Munteanu, M. F., Golumbeanu, M., BOGHIȚOIU, D. A., Dărăban, A. M., Ilie, E. I., & Moroșan, E. (2024) · Antibodies · doi:10.3390/antib13020047 · Cited by 6
Aiolos promotes CXCR3 expression on Th1 cells via positive regulation of IFN-γ/STAT1 signaling
Leonard, M. R., Jones, D. M., Read, K. A., Pokhrel, S., Tuazon, J. A., Warren, R. T., Yount, J. S., & Oestreich, K. J. (2024) · JCI Insight · doi:10.1172/jci.insight.180287 · Cited by 8
Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre study
Baldi, C., Gentileschi, S., Gobbi, F. L., Cazzato, M., Sedie, A. D., Gaggiano, C., D’Ignazio, E., Lepri, G., Lorenzo, C. D., Nannini, C., et al. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01578-2 · Cited by 6
Take (STAT)5: jazzing up T-cell leukemia
Porcu, P., & Dubovsky, J. A. (2014) · Blood · doi:10.1182/blood-2014-06-576942 · Cited by 6
Low concentration arsenite activated JAK2/STAT3 signal and increased proliferative factor expressions in SV‐HUC‐1cells after short and long time treatment
Li, M., Chen, W., Jieyu, L., Peiyu, J., Fei, W., Liu, S., & Xi, S. (2017) · Environmental Toxicology · doi:10.1002/tox.22428 · Cited by 6
β-Glucan augments IL-1β production by activating the JAK2/STAT3 pathway in cultured rabbit keratinocytes
Xiao, W., Fu, L., Gu, C., Wang, R., Zhao, M., Wang, J., Jia, X., Chen, S., & Lai, S. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104175 · Cited by 7
Synergistic effects of autocrine motility factor and methyl jasmonate on human breast cancer cells
Jeoung, N. H., Jo, A. L., & Park, H. S. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.04.054 · Cited by 6
Identification of serum and glucocorticoid-regulated kinase 1 as a regulator of signal transducer and activator of transcription 3 signaling
Araki, T., Watanabe, Y., Okada, Y., Murakami, H., Ogo, N., & Asai, A. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113079 · Cited by 6
High prevalence of low-allele-fraction somatic mutations in STAT3 in peripheral blood CD8+ cells in multiple sclerosis patients and controls
Valori, M., Lehikoinen, J., Jansson, L., Clancy, J., Lundgren, S., Mustjoki, S. M., & Tienari, P. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278245 · Cited by 6
Natural killer cells in patients with polycythemia vera
Sanchez, C., Baier, C., Colle, J., Chelbi, R., Rihet, P., Treut, T. L., Imbert, J., Sébahoun, G., Venton, G., & Costello, R. T. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.09.010 · Cited by 6
L’axe GH-IGF-I dans la croissance
Castell, A., Sadoul, J., & Bouvattier, C. M. (2013) · Annales d Endocrinologie · doi:10.1016/s0003-4266(13)70019-2 · Cited by 6
Molecular deregulation of signaling in lymphoid tumors
Spina, V., Martuscelli, L., & Rossi, D. (2015) · European Journal Of Haematology · doi:10.1111/ejh.12567 · Cited by 6
Autosomal dominant transmission of signal transduction and activator of transcription 1 (STAT1) mutation (Thr385Met) and extended lifespan
Wessell, K. R., Tcheurekdjian, H., & Hostoffer, R. (2016) · LymphoSign Journal · doi:10.14785/lpsn-2015-0013 · Cited by 6
A novel EGFR-TKI inhibitor (cAMP-H3BO3complex) combined with thermal therapy is a promising strategy to improve lung cancer treatment outcomes
Tong, Y., Huang, C., & Zhang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17628 · Cited by 6
EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis
Prem, S., Loach, D., Lipton, J. H., Kumar, R., & Gupta, V. K. (2019) · Blood Research · doi:10.5045/br.2019.54.4.282 · Cited by 6
Calculation of binding affinity of JAK1 inhibitors via accurately computational estimation
Le, T.-T.-H., Tran, L. H., Nguyen, M. T., Pham, M. Q., & Phùng, H. T. T. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2118830 · Cited by 6
Type I Interferon Mimetics Bypass Vaccinia Virus Decoy Receptor Virulence Factor for Protection of Mice against Lethal Infection
Ahmed, C. M. I., & Johnson, H. M. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00204-14 · Cited by 6
Baricitinib for rheumatoid arthritis
Zamora, N. V., Tayar, J. H., Lopez-Olivo, M. A., Christensen, R., & Suarez-Almazor, M. E. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013311 · Cited by 6
Sensitive Transcriptomics and Genotyping reveals function of genetic variants in immunityPreprint
Liu, K., Rasmussen, A. W., Han, W., Gong, Q., Bohley, S., Chen, X. D., Kanai, M., Maronick, R., Yin, Z., Hu, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.12.642879 · Cited by 6
Monocyte STAT1 phosphorylation and treatment response of JAK inhibitors in chronic nonbacterial osteomyelitis
Sonoda, M., Kinoshita, K., Harada, N., Park, S., Adachi, S., Yada, Y., Eguchi, K., Fujiwara, T., Kido‐Nakahara, M., Kinjo, N., et al. (2025) · Pediatric Rheumatology · doi:10.1186/s12969-025-01059-6 · Cited by 5
Developing potent anti-inflammatory IRAK4-targeting PROTACs with simplified CRBN ligands
Li, Z., Song, P., Liu, Y., Sun, X., Zhai, X., & Rao, Y. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111033 · Cited by 5
Ruxolitinib Suppresses Interferon‐γ‐Induced JAK/STAT Activation in Oral Keratinocytes
Stolte, K. N., Fedorova, A., Attia, S., Danker, K., & Dommisch, H. (2026) · Clinical and Experimental Dental Research · doi:10.1002/cre2.70281 · Cited by 5
Safety and efficacy of different JAK inhibitors in the treatment of inflammatory bowel disease: a network meta-analysis
Wu, H., Zhou, Y., Chen, X., Wang, L., Guo, Y., Du, X., & Miao, X. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1699928 · Cited by 5
Upregulation of tumor suppressor PIAS3 by Honokiol promotes tumor cell apoptosis via selective inhibition of STAT3 tyrosine 705 phosphorylation
Fei, Y., Zhang, X., Wang, X., Sun, Y., He, J. W., Liu, X., Song, Z., Qiu, L., Qiu, L., Qian, Z., et al. (2023) · Journal of Natural Medicines · doi:10.1007/s11418-023-01757-z · Cited by 5
Unraveling the immunogenetics of STAT proteins: Clinical perspectives on gain-of-function and loss-of-function variants
Meesilpavikkai, K., Hirankarn, N., Dalm, V. A. S. H., van Hagen, P. M., Dik, W. A., & IJspeert, H. (2024) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-270124-1776 · Cited by 5
Quinazoline-2,4(1H,3H)-dione modulates STAT3 and FOXO3a signaling in HepG2 cells
Manoharan, S., Murugesan, K., Gunasekaran, S., Vedagiri, H., & Perumal, E. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108304 · Cited by 6
Constitutive systemic inflammation in Shwachman-Diamond Syndrome
Sabbioni, G., D’Aversa, E., Breveglieri, G., Altieri, M. T., Boni, C., Pegoraro, A., Finotti, A., Gambari, R., D’Amico, G., Vella, A., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01133-5 · Cited by 7
FastCCC: a permutation-free framework for scalable, robust, and reference-based cell-cell communication analysis in single cell transcriptomics studies
Hou, S., Ma, W., & Zhou, X. (2025) · Nature Communications · doi:10.1038/s41467-025-66272-z · Cited by 6
Occurrence of Extensive Cutaneous Human Papillomavirus Infection After Initiation of Tofacitinib Therapy
Brunet‐Possenti, F., Charpentier, C., Bouhnik, Y., Deschamps, L., Descamps, D., Moins‐Teisserenc, H., & Descamps, V. (2019) · JAMA Dermatology · doi:10.1001/jamadermatol.2018.5528 · Cited by 5
Investigation of the Detailed AMPylated Reaction Mechanism for the Huntingtin Yeast-Interacting Protein E Enzyme HYPE
Liu, M., Huai, Z., Tan, H., & Chen, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136999 · Cited by 5
TIAM2 promotes proliferation and invasion of osteosarcoma cells by activating the JAK2/STAT3 signaling pathway
Cheng, S., Huang, X., & Guo, W. (2022) · Journal of bone oncology · doi:10.1016/j.jbo.2022.100461 · Cited by 5
Making a prescribing choice for rheumatoid arthritis: a focus on small molecule drugs vs. biologics for the most favourable patient outcome
Tanaka, Y. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2247325 · Cited by 5
Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders
Failing, C., Blase, J. R., & Walkovich, K. J. (2023) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2023.07.001 · Cited by 5
Autoimmunity in Primary Immunodeficiency Disorders
Kitcharoensakkul, M., & Cooper, M. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812102-3.00028-2 · Cited by 5
Comparative Efficacy and Tolerability of Janus Kinase Inhibitor Therapies for Moderate to Severe Crohn’s Disease: Α Network Meta-analysis
Rokkas, T., Ekmektzoglou, K. A., & Niv, Y. (2021) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-3804 · Cited by 5
Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma
Trojan, A., Lone, Y. C., Briceño, I., & Trojan, J. (2023) · Current Medicinal Chemistry · doi:10.2174/0109298673237968231106095141 · Cited by 5
Shifting paradigm of developing biologics for the treatment of pancreatic adenocarcinoma
Zeng, Y., Rucki, A. A., Che, X., & Zheng, L. (2017) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2016.10.02 · Cited by 5
HiJAKing the epigenome in leukemia and lymphoma
Drennan, A. C., & Rui, L. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1312370 · Cited by 5
Leveraging JAK-STAT regulation in myelofibrosis to improve outcomes with allogeneic hematopoietic stem-cell transplant
Byrne, M. T., Savani, B. N., & Savona, M. R. (2018) · Therapeutic Advances in Hematology · doi:10.1177/2040620718786437 · Cited by 5
Keeping each other in check: A reciprocal relationship between cytokines and miRNA
Andersen, M. H. (2013) · Cell Cycle · doi:10.4161/cc.25549 · Cited by 5
Duox and Jak/Stat signalling influence disease tolerance in Drosophila during Pseudomonas entomophila infectionPreprint
Prakash, A., Monteith, K. M., Bonnet, M., & Vale, P. F. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.23.461578 · Cited by 5
Blockade of rheumatoid arthritis synovial fluid-induced sensory neuron activation by JAK inhibitorsPreprint
Li, Y., Gray, E. H., Ross, R., Zebochin, I., Lock, A., Fedele, L., Kamajaya, L. J., Marrow, R. J., Ryan, S. E., Röderer, P., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.19.608613 · Cited by 5
Structural analysis reveals how tetrameric tyrosine-phosphorylated STAT1 is targeted by the rabies virus P-protein
Sugiyama, A., Minami, M., Ugajin, K., Inaba‐Inoue, S., Yabuno, N., Takekawa, Y., Xiaomei, S., Takei, S., Sasaki, M., Nomai, T., et al. (2025) · Science Signaling · doi:10.1126/scisignal.ads2210 · Cited by 4
Dexmedetomidine regulates the SIRT3-mediated JAK2/STAT3 signaling pathway to protect against sepsis-induced intestinal injury
Gu, H., Xu, L., Yu, X., Xiang, J., Shan, Y., & Ye, G. (2025) · Scientific Reports · doi:10.1038/s41598-025-18938-3 · Cited by 4
A hybrid energy-based and AI-based screening approach for the discovery of novel inhibitors of JAK3
Wei, J., Pan, Y., Shen, Z., Shen, L., Xu, L., Yu, W., & Huang, W. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1182227 · Cited by 4
Flavipin from fungi as a potential inhibitor of rheumatoid arthritis signaling molecules
Ahmed, E. A., Alzahrani, A. M., Abdelsalam, S. A., & Ibrahim, H.-I. M. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01429-8 · Cited by 4
The Role of Pretreatment Serum Interleukin 6 in Predicting Short-Term Mortality in Patients with Advanced Pancreatic Cancer
Park, S. J., Park, J. Y., Shin, K., Hong, T. H., Kim, Y.-H., Kim, I.-H., & Lee, M. A. (2024) · Biomedicines · doi:10.3390/biomedicines12040903 · Cited by 4
Re-evaluating Methods for Assessing Differences in Response in Ileal vs Colonic Crohn’s Disease: A Post-hoc Analysis of the FITZROY Trial
Ma, C., Feagan, B. G., Wang, Z., Zou, G., Smith, M. I., Shackelton, L. M., Sands, B. E., Panaccione, R., D’Haens, G., Vermeire, S., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae113 · Cited by 4
B-cell acute lymphoblastic leukemia with +der(1)t(1;19) (p13;p13.1) arising in the setting of CALR exon 9 mutated essential thrombocythemia
Hilal, T., & Conley, C. R. (2017) · Cancer Genetics · doi:10.1016/j.cancergen.2017.10.001 · Cited by 4
Study on the binding mode of a pyrrolotriazin derivative with JAK2 by docking and MD simulation
Gao, H., Mei, S., Zhao, J., Zheng, K., & Liao, S. (2018) · Molecular Simulation · doi:10.1080/08927022.2018.1557330 · Cited by 4
Janus Kinase Inhibitors
Kim, A., & Strober, B. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-66884-0_19 · Cited by 4
A new discovery of STAT4 single nucleotide polymorphisms associated with hepatocellular carcinoma risk in Chinese Han population: a case–control study
Xu, C., Wu, J., Zhang, W., Feng, X., Zhao, L., Huang, F., & Jiang, C. Q. (2021) · Bioscience Reports · doi:10.1042/bsr20210124 · Cited by 4
Gain-of-function STAT1 mutation and visceral leishmaniasis
Lyra, P. T., Falcão, A. C. A. M., Cruz, R. A., Coelho, A. V. C., Souza, E. D. S., de Alencar, L. C. A., & Oliveira, J. B. (2022) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2022rc0048 · Cited by 4
Network Approaches to Uncover Pathogenesis and Therapeutic Targets of Inflammatory Bowel Diseases
Mikami, Y., & Kanai∥, T. (2023) · The Keio Journal of Medicine · doi:10.2302/kjm.2022-0015-ir · Cited by 4
L-theanine regulates the immune function of SD rats fed high-protein diets through the FABP5/IL-6/STAT3/PPARα pathway
Zhang, Y., Song, Y., Zhang, J., Li, L., He, L., Bo, J., Gong, Z., & Xiao, W. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.114095 · Cited by 4
Drug retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in Korean patients with seropositive rheumatoid arthritis
Lee, B.-W., Lee, J. J., & Kim, W. (2024) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2023.297 · Cited by 4
Gene Activation by the Cytokine-Driven Transcription Factor STAT1
Nast, R., Staab, J., & Meyer, T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82699 · Cited by 4
JAK Inhibitors for Rheumatoid Arthritis
Cohen, M. D., & Keystone, E. C. (2015) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-015-0030-7 · Cited by 4
A rare case of primary cutaneous follicle centre lymphoma presenting as a giant tumour of the scalp and combined with JAK2V617F positive essential thrombocythaemia
Tirefort, Y., Pham, X.-C., Ibrahim, Y. L., Lecompte, T., Matthes, T., Prins, C., Cortès, B., Bernimoulin, M. P., Chalandon, Y., & Samii, K. (2014) · Biomarker Research · doi:10.1186/2050-7771-2-7 · Cited by 4
Novel Intra-cellular Targeting Agents in Rheumatic Disease
Cohen, S. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00065-6 · Cited by 4
The JAK–STAT–SOCS Signaling Cascade
Murphy, J. M., Babon, J. J., Nicola, N. A., & Nicholson, S. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394447-4.30016-5 · Cited by 4
Cytokine regulation of mammary gland development and epithelial cell functions through discrete activities of Stat proteins
Groner, B., & Vafaizadeh, V. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.08.019 · Cited by 4
Structural models of full-length JAK2 kinasePreprint
Ayaz, P., Hammarén, H. M., Raivola, J., Sharon, D. A., Hubbard, S. R., Silvennoinen, O., Shan, Y., & Shaw, D. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/727727 · Cited by 4
Wooldridge memorial lecture. The role of vets in society.
Armour, J. (1990) · PubMed · Cited by 4
Enhanced Complex Stability and Optimal JAK Geometry are Pivotal for a Potent Type III Interferon ResponsePreprint
Aung, T., Horvath, C. M., & Mendoza, J. L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.27.508945 · Cited by 4
Direct reprogramming of human fibroblasts into hair-inducing dermal papilla cell-like cells by a single small molecule
Zeng, Q., Ma, Y., Cai, R., Li, X., Luo, Y., Zheng, B., Wang, G., Xu, X., Wang, X., & Liu, Z. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116744 · Cited by 3
Development and validation of a sensitive LC-MS/MS assay for determination of upadacitinib in human plasma and its application in patients with inflammatory bowel disease
Wu, J., Lin, L., Yan, J.-J., Kong, J.-H., Xuan, Q., Gao, X., Chao, K., & Zhu, X. (2025) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2025.107581 · Cited by 3
Epigenetic responses in Borrelia-infected Ixodes scapularis ticks: Over-expression of euchromatic histone lysine methyltransferase 2 and no change in DNA methylation
MacIntosh, G. H., Nuyens, A. C., Vickery, J. L., Berthold, A., & Lloyd, V. K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324546 · Cited by 3
A twist in the tale: shifting from covalent targeting of a tyrosine in JAK3 to a lysine in MK2
Hillebrand, L., Wang, G., Rasch, A., Masberg, B., Chaikuad, A., Kronenberger, T., Günther, E., Förster, M., Poso, A., Lämmerhofer, M., et al. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00440c · Cited by 3
Identification of Novel JAK2 Inhibitors from Amino Derivatives of Epoxyalantolactone: In Silico and In Vitro Studies
Todsaporn, D., Sanachai, K., Aonbangkhen, C., Poo-arporn, R. P., Kartsev, V. G., Pukhov, S. A., Afanasyeva, S., Geronikaki, A. A., & Rungrotmongkol, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010329 · Cited by 3
JAK-STAT signaling pathway-related gene single nucleotide polymorphisms and susceptibility to ankylosing spondylitis in eastern Chinese Han population
Deng, Y., Xu, W., Gao, X., Chen, Y., Yang, H., Shao, M., & Pan, F. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06435-1 · Cited by 3
Catalytic deAMPylation in AMPylation-inhibitory/assistant forms of FICD protein
Liu, M., Li, L., Wang, Z., Wang, S., & Tang, X. (2023) · Frontiers in Chemistry · doi:10.3389/fchem.2023.1077188 · Cited by 3
Myb Repression Mediates Stat5b-knockdown-induced Apoptosis and Inhibits Proliferation of Glioblastoma Stem Cells
Moyama, C., Fujita, M., Okamoto, H., Ii, H., & Nakata, S. (2023) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20374 · Cited by 3
Single-cell mass cytometry in immunological skin diseases
Zhao, M., Cheng, Y., Gao, J., & Zhou, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1401102 · Cited by 4
Design of a potent and selective dual JAK1/TYK2 inhibitor
Mammoliti, O., Menet, C. J., Cottereaux, C., Blanc, J., Blieck, A. D., Coti, G., Geney, R., Oste, L., Ostyn, K., Palisse, A., et al. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117932 · Cited by 3
Involvement and Therapeutic Implication of JAK-STAT Pathway in Cancer
Rehman, A., Khan, N. A., Rashid, G., Tamanna, S., Jindal, R., Seth, N., Bashir, B., Mushtaq, G., Salman, M., & Parveen, S. (2025) · Springer eBooks · doi:10.1007/978-981-96-2763-9_8 · Cited by 5
Intrazelluläre Targets
Alten, R. (2013) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-013-1139-4 · Cited by 3
Rosette Assay: Highly Customizable Dot-Blot for SH2 Domain Screening
Ng, K. Y., & Machida, K. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6762-9_26 · Cited by 3
Human diseases caused by impaired signal transducer and activator of transcription and Janus kinase signaling
Chaimowitz, N. S., & Forbes, L. R. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000841 · Cited by 5
The Positivity of Phosphorylated STAT3 Is a Novel Marker for Favorable Prognosis in Germinal Center B-Cell Type of Diffuse Large B-Cell Lymphoma
Morichika, K., Karube, K., Sakihama, S., Watanabe, R., Kawaki, M., Nishi, Y., Nakachi, S., Okamoto, S., Takahara, T., Satou, A., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001691 · Cited by 3
Intracellular Signaling
Hanrahan, A. J., Iyer, G., & Solit, D. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00002-5 · Cited by 5
Transcription Factors and Regulators Pathway-focused Genes Expression Analysis in Patients with Different Forms of Thyroid Pathology
Kamyshna, I. I., & Kamyshnyi, O. (2022) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023666220217123454 · Cited by 3
A computationally affordable approach for accurate prediction of the binding affinity of JAK2 inhibitors
Thị, N., Lan, N. T., Vu, T. Y., Tùng, N. T., & Phùng, H. T. T. (2022) · Journal of Molecular Modeling · doi:10.1007/s00894-022-05149-0 · Cited by 3
STAT3-EphA7 axis contributes to the progression of esophageal squamous cell carcinoma
Wang, L., Zhao, Q., Yang, B., Liang, H.-J., Zhang, X., Zhang, X., Yang, W., Guo, Z.-Y., Xu, X., Tian, F., et al. (2023) · Acta Oncologica · doi:10.1080/0284186x.2023.2259601 · Cited by 3
What's in a name: the multifaceted function of DNA ‐ and RNA ‐binding proteins in T cell responses
Bresser, K., Popović, B., & Wolkers, M. C. (2024) · FEBS Journal · doi:10.1111/febs.17273 · Cited by 3
Janus Kinase Inhibitors in Dermatology
Bubna, A. (2019) · Indian Journal of Drugs in Dermatology · doi:10.4103/ijdd.ijdd_38_18 · Cited by 3
Role of Inflammatory Cytokines in the Initiation and Progression of Pancreatic Cancer
Santharam, M. A., & Dhandapani, V. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_8 · Cited by 3
Genetic variants in STAT4 and their interactions with environmental factors for the incidence of hepatocellular carcinoma
Zhong, X., Luo, M., Wu, Y., Zhou, X., Yu, X., Liu, L., & Chen, S. (2021) · Cancer Biomarkers · doi:10.3233/cbm-203162 · Cited by 3
Mendelian disorders of immunity related to an upregulation of type I interferon
Frémond, M., & Crow, Y. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816768-7.00032-6 · Cited by 3
Updates in Pediatric Rheumatology
McCurdy, D. (2016) · Advances in Pediatrics · doi:10.1016/j.yapd.2016.04.006 · Cited by 3
EGFR induces DNA decomposition via phosphodiester bond cleavage
Tong, Y., Li, S., & Huang, C. (2017) · Scientific Reports · doi:10.1038/srep43698 · Cited by 3
RUSSIAN AND INTERNATIONAL EXPERIENCE IN THE APPLICATION OF THE JANUS-KINASES INHIBITOR IN RHEUMATOID ARTHRITIS
Karateev, D. E., Лучихина, Е. Л., & Misiyuk, A. S. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-10-87-92 · Cited by 3

Authors: O'Shea, J. J., Holland, S. M., & Staudt, L. M.
Affiliations: National Institute of Allergy and Infectious Diseases (US)
National Institutes of Health (US)
ORCID: Holland, Steven M.
Staudt, Louis M.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2013-01-10
Volume: 368
Issue: 2
Pages: 161-170
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra1202117
PMC: PMC7604876
OpenAlex: W2040002852
Cited by: 927
References: 101
Citations by year: 2026: 47 · 2025: 61 · 2024: 64 · 2023: 76 · 2022: 79 · 2021: 91 · 2020: 78 · 2019: 60 · 2018: 44 · 2017: 70 · 2016: 66 · 2015: 69 · 2014: 67 · 2013: 52
FWCI: 8.98
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Cancer Institute (Z01SC004024)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (ZIAAR041106)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords: JAK/STAT signaling, cytokine signaling, immunodeficiency, cancer, immune regulation, JAK inhibitors, STAT inhibitors, targeted therapy
MeSH terms: Hematologic Diseases, Humans, Immunologic Deficiency Syndromes, Mutation, Neoplasms, Signal Transduction, Cytokines, STAT Transcription Factors, Janus Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

JAKs and STATs in Immunity, Immunodeficiency, and Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks